PTHS logo

PTHSPelthos Therapeutics Inc.

$27.50
$1.22
(4.25%)
Today
Closed $27.50
$0.00
(0.00%)
After Hours
Updated: 04:04 PM EDT
EarningsAug 13
Mkt Cap$95.58M
Vol1,609.00
News
all
press releases
News Placeholder
Pelthos Therapeutics Inc. (PTHS) Reports Q1 Loss, Beats Revenue Estimates
Pelthos Therapeutics Inc. (PTHS) delivered earnings and revenue surprises of +22.75% and +12.03%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Pelthos Therapeutics Inc. (PTHS) Reports Q4 Loss, Tops Revenue Estimates
Pelthos Therapeutics Inc. (PTHS) delivered earnings and revenue surprises of +28.35% and +3.78%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts
The launch triggered a $5 million milestone payment to Ligand, which also holds a 56% stake in Pelthos and is eligible for royalties and additional commercial milestones.
Stocktwits
<
...
1
>

Advertisement|Remove ads.